# Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

> **NCT03131167** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 63 (actual)

## Conditions studied

- Primary Open-angle Glaucoma (POAG)
- Ocular Hypertension

## Interventions

- **DRUG:** SHP639 (n=60)
- **DRUG:** Placebo Comparator (n=24)

## Key facts

- **NCT ID:** NCT03131167
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-10
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131167, "Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03131167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*